# RemSleep Holdings Inc.: financial statements, quarterly

RMSL · OTC · CIK 1412126 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rmsl.md) · [Financials](/companies/rmsl/financials.md) · [Filings](/companies/rmsl/filings.md) · [Insiders](/companies/rmsl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rmsl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [51.9](/filings/0001213900-24-098212.md) | [7.5 d](/filings/0001213900-25-031599.md) | [57.9](/filings/0001213900-25-042723.md) | [27.6](/filings/0001213900-25-076381.md) | [37.3](/filings/0001213900-25-112640.md) | [(5.6) d](/filings/0001213900-26-044165.md) | not reported | [4.8](/filings/0001213900-25-076381.md) | [7.5](/filings/0001213900-25-112640.md) | [4.4 d](/filings/0001213900-26-044165.md) | not reported | not reported |
| Cost of revenue | $k | [49.9](/filings/0001213900-24-098212.md) | [787 d](/filings/0001213900-25-031599.md) | [13.6](/filings/0001213900-25-042723.md) | [5.9](/filings/0001213900-25-076381.md) | [58.6](/filings/0001213900-25-112640.md) | [21.1 d](/filings/0001213900-26-044165.md) | not reported | [0.6](/filings/0001213900-25-076381.md) | [0.0](/filings/0001213900-25-112640.md) | [12.1 d](/filings/0001213900-26-044165.md) | not reported | not reported |
| Gross profit | $k | [2.0](/filings/0001213900-24-098212.md) | [(779) d](/filings/0001213900-25-031599.md) | [44.3](/filings/0001213900-25-042723.md) | [21.7](/filings/0001213900-25-076381.md) | [(21.3)](/filings/0001213900-25-112640.md) | [(26.6) d](/filings/0001213900-26-044165.md) | not reported | [4.2](/filings/0001213900-25-076381.md) | [7.4](/filings/0001213900-25-112640.md) | [(7.6) d](/filings/0001213900-26-044165.md) | not reported | not reported |
| Research and development | $k | [13.9](/filings/0001213900-24-098212.md) | [205 d](/filings/0001213900-25-031599.md) | [22.2](/filings/0001213900-25-042723.md) | [132](/filings/0001213900-25-076381.md) | [40.8](/filings/0001213900-25-112640.md) | [(9.4) d](/filings/0001213900-26-044165.md) | [17.2](/filings/0001213900-26-066990.md) | [1.5](/filings/0001213900-25-076381.md) | [0.0 d](/filings/0001213900-25-112640.md) | not reported | not reported | not reported |
| Operating income | $k | [(271)](/filings/0001213900-24-098212.md) | [(1,058) d](/filings/0001213900-25-031599.md) | [(124)](/filings/0001213900-25-042723.md) | [(297)](/filings/0001213900-25-076381.md) | [(194)](/filings/0001213900-25-112640.md) | [(178) d](/filings/0001213900-26-044165.md) | [(131)](/filings/0001213900-26-066990.md) | [(133)](/filings/0001213900-25-076381.md) | [(2,283)](/filings/0001213900-25-112640.md) | [(221) d](/filings/0001213900-26-044165.md) | [(231)](/filings/0001213900-26-066990.md) | [(36.3) d](/filings/0001683168-26-006414.md) |
| Interest expense | $k | [0.0 d](/filings/0001213900-23-087172.md) | [6.7 d](/filings/0001213900-24-033498.md) | [2.6](/filings/0001213900-24-047539.md) | [32.9](/filings/0001213900-25-076381.md) | [64.4](/filings/0001213900-25-112640.md) | [17.8 d](/filings/0001213900-26-044165.md) | [76.3](/filings/0001213900-26-066990.md) | [144](/filings/0001213900-25-076381.md) | [130](/filings/0001213900-25-112640.md) | [38.0 d](/filings/0001213900-26-044165.md) | [51.3](/filings/0001213900-26-066990.md) | [32.6 d](/filings/0001683168-26-006414.md) |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(270)](/filings/0001213900-24-098212.md) | [(1,058) d](/filings/0001213900-25-031599.md) | [(253)](/filings/0001213900-25-112640.md) | [(226)](/filings/0001213900-25-112640.md) | [(278)](/filings/0001213900-25-112640.md) | [(322) d](/filings/0001213900-26-044165.md) | [(85.5)](/filings/0001213900-26-066990.md) | [(288)](/filings/0001213900-25-112640.md) | [(2,312)](/filings/0001213900-25-112640.md) | [(335) d](/filings/0001213900-26-044165.md) | [(290)](/filings/0001213900-26-066990.md) | [(103) d](/filings/0001683168-26-006414.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001213900-24-098212.md) | not reported | [0.00](/filings/0001213900-25-042723.md) | [0.00](/filings/0001213900-25-076381.md) | [0.00](/filings/0001213900-25-112640.md) | not reported | [0.00](/filings/0001213900-26-066990.md) | [0.00](/filings/0001213900-25-076381.md) | [0.00](/filings/0001213900-25-112640.md) | not reported | [0.00](/filings/0001213900-26-066990.md) | not reported |
| Basic EPS | $ per share | [0.00](/filings/0001213900-24-098212.md) | not reported | [0.00](/filings/0001213900-25-042723.md) | [0.00](/filings/0001213900-25-076381.md) | [0.00](/filings/0001213900-25-112640.md) | not reported | [0.00](/filings/0001213900-26-066990.md) | [0.00](/filings/0001213900-25-076381.md) | [0.00](/filings/0001213900-25-112640.md) | not reported | [0.00](/filings/0001213900-26-066990.md) | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | [904](/filings/0001213900-23-087172.md) | [719](/filings/0001213900-25-031599.md) | [731](/filings/0001213900-24-047539.md) | [699](/filings/0001213900-24-070805.md) | [535](/filings/0001213900-24-098212.md) | [463](/filings/0001213900-26-044165.md) | [507](/filings/0001213900-25-042723.md) | [416](/filings/0001213900-25-076381.md) | [344](/filings/0001213900-25-112640.md) | [215](/filings/0001683168-26-006414.md) | [88.0](/filings/0001213900-26-066990.md) | not reported |
| Current assets | $k | [1,838](/filings/0001213900-23-087172.md) | [836](/filings/0001213900-25-031599.md) | [844](/filings/0001213900-24-047539.md) | [805](/filings/0001213900-24-070805.md) | [598](/filings/0001213900-24-098212.md) | [492](/filings/0001213900-26-044165.md) | [526](/filings/0001213900-25-042723.md) | [437](/filings/0001213900-25-076381.md) | [373](/filings/0001213900-25-112640.md) | [265](/filings/0001683168-26-006414.md) | [161](/filings/0001213900-26-066990.md) | [79.3](/filings/0001683168-26-006414.md) |
| Total assets | $k | [2,268](/filings/0001213900-23-087172.md) | [1,206](/filings/0001213900-25-031599.md) | [1,160](/filings/0001213900-24-047539.md) | [1,066](/filings/0001213900-24-070805.md) | [810](/filings/0001213900-24-098212.md) | [592](/filings/0001213900-26-044165.md) | [605](/filings/0001213900-25-042723.md) | [542](/filings/0001213900-25-076381.md) | [464](/filings/0001213900-25-112640.md) | [340](/filings/0001683168-26-006414.md) | [224](/filings/0001213900-26-066990.md) | [154](/filings/0001683168-26-006414.md) |
| Current liabilities | $k | [192](/filings/0001213900-23-087172.md) | [232](/filings/0001213900-25-031599.md) | [467](/filings/0001213900-24-047539.md) | [494](/filings/0001213900-24-070805.md) | [176](/filings/0001213900-24-098212.md) | [255](/filings/0001213900-26-044165.md) | [354](/filings/0001213900-25-042723.md) | [385](/filings/0001213900-25-076381.md) | [202](/filings/0001213900-25-112640.md) | [300](/filings/0001683168-26-006414.md) | [342](/filings/0001213900-26-066990.md) | [397](/filings/0001683168-26-006414.md) |
| Total liabilities | $k | [279](/filings/0001213900-23-087172.md) | [276](/filings/0001213900-25-031599.md) | [481](/filings/0001213900-24-047539.md) | [494](/filings/0001213900-24-070805.md) | [176](/filings/0001213900-24-098212.md) | [255](/filings/0001213900-26-044165.md) | [354](/filings/0001213900-25-042723.md) | [402](/filings/0001213900-25-076381.md) | [215](/filings/0001213900-25-112640.md) | [308](/filings/0001683168-26-006414.md) | [346](/filings/0001213900-26-066990.md) | [435](/filings/0001683168-26-006414.md) |
| Long-term debt | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $k | [1,989](/filings/0001213900-24-098212.md) | [931](/filings/0001213900-26-044165.md) | [678](/filings/0001213900-25-112640.md) | [573](/filings/0001213900-25-112640.md) | [634](/filings/0001213900-25-112640.md) | [337](/filings/0001213900-26-066990.md) | [251](/filings/0001213900-26-066990.md) | [140](/filings/0001213900-25-112640.md) | [249](/filings/0001213900-25-112640.md) | [32.1](/filings/0001683168-26-006414.md) | [(123)](/filings/0001213900-26-066990.md) | [(281)](/filings/0001683168-26-006414.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(170) d](/filings/0001213900-24-098212.md) | [(174) d](/filings/0001213900-25-031599.md) | [(113)](/filings/0001213900-25-042723.md) | [(152) d](/filings/0001213900-25-076381.md) | [(272) d](/filings/0001213900-25-112640.md) | [(145) d](/filings/0001213900-26-044165.md) | [(110)](/filings/0001213900-26-066990.md) | [(141) d](/filings/0001213900-25-076381.md) | [(122) d](/filings/0001213900-25-112640.md) | [(129) d](/filings/0001213900-26-044165.md) | [(177)](/filings/0001213900-26-066990.md) | [(242) d](/filings/0001683168-26-006414.md) |
| Capital expenditure | $k | [7.5 d](/filings/0001213900-24-098212.md) | [11.7 d](/filings/0001213900-25-031599.md) | not reported | not reported | not reported | [51.0 d](/filings/0001213900-26-044165.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,426](/filings/0001213900-23-068698.md) | [1,462](/filings/0001213900-23-087172.md) | [1,462](/filings/0001213900-24-047539.md) | [1,462](/filings/0001213900-24-070805.md) | [1,462](/filings/0001213900-24-098212.md) | [1,462](/filings/0001213900-25-042723.md) | [1,472](/filings/0001213900-25-076381.md) | [1,511](/filings/0001213900-25-112640.md) | [1,526](/filings/0001213900-26-066990.md) | [1,544](/filings/0001213900-25-076381.md) | [1,577](/filings/0001213900-25-112640.md) | [1,690](/filings/0001213900-26-066990.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,739,610,123 at 2026-06-30, from the cover of the [10-Q filed 2026-08-14](/filings/0001683168-26-006414.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.